A prospective study of severity of complications associated with use of misoprostol and other abortion methods in South West Nigeria.
Abortion methods
Induced abortion
Misoprostol
Nigeria
Postabortion complications
Unsafe abortion
Journal
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
ISSN: 1879-3479
Titre abrégé: Int J Gynaecol Obstet
Pays: United States
ID NLM: 0210174
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
02
07
2018
revised:
15
02
2019
accepted:
30
05
2019
pubmed:
4
6
2019
medline:
16
10
2019
entrez:
2
6
2019
Statut:
ppublish
Résumé
To assess the severity of complications following misoprostol used to induce abortion compared with other methods among women admitted for postabortion complications. A cross-sectional study of women who presented with complications of induced abortion at nine secondary and tertiary hospitals in South West Nigeria between April 1, 2013 and May 31, 2014. Face-to-face interviews were conducted and information on the current admission was extracted from patient records. Associations between abortion method used and severity of abortion complications were evaluated using χ Of 522 women included in the study, 177 reported an induced abortion: 41 women (23.2%) had used misoprostol at the first attempt to induce abortion, whereas 79 (44.6%) women had undergone surgical abortion. Occurrence of fever (P=0.06), bleeding (P=0.3), and lower abdominal pain (P=0.32) was not significantly different between the misoprostol and surgical abortion/other methods groups. Severe complications were rare with misoprostol, but more common among women in the surgical abortion/other methods group. Maternal mortality occurred only among women in the surgical abortion/other methods group. Use of misoprostol for induced abortion was associated with fewer complications and no maternal mortality compared with surgical abortion/other methods.
Substances chimiques
Abortifacient Agents, Nonsteroidal
0
Misoprostol
0E43V0BB57
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
302-307Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : WHO
Organisme : UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)
Informations de copyright
© 2019 International Federation of Gynecology and Obstetrics.